The Healing Power of Botanical Therapeutics®


Herborium Group Presented at The National Investment Banking Association, Inc. (NIBA) Conference in New York City, June 6th-8th, 2012 Herborium Receives Term Sheet From China Health Resource, Inc.

Press Release: Herborium Group, Inc. — Mon, June 11, 2012 8:45 AM EDT

FORT LEE, N.J., June 11, 2012 /PRNewswire/ -- Herborium Group, Inc. ( is pleased to report that the presentation of the Company's unique Botanical Therapeutics® opportunity at the National Investment Banking Association, Inc. (NIBA) meeting in New York City, June 6th-8th, 2012 resulted in number of interests by NIBA professional members.  To date NIBA member firms have successfully completed some 1000+ equity offerings totaling approximately $10 billion in new capital for America's emerging growth companies.  "We are very pleased with a response we have received at the Conference and expect number of growth opportunities to be afforded to Herborium by this great exposure," commented Dr. Olszewski, CEO of Herborium. The member firms of NIBA represent over 8800 registered representatives with estimated $78 billion assets under management.

In addition to the presentation and series of one-on-one meetings hold by the Management of Herborium at the Conference, Dr. Agnes P. Olszewski has been interviewed at the Conference by and

Just before the Conference that is on Tuesday, June 5th, 2012, Herborium received a Term Sheet from China Health Resource, Inc. for a review and consideration of the investment/acquisition offer. Herborium Management and counsel will diligently review the offer in due time.

About Herborium Group, Inc.

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals.  The Company uses clinical validation to establish and maintain a differential advantage. The company sales its products in the US and Europe. For more information, please visit and

One of our most important responsibilities is to communicate with shareholders in an open and direct manner.  Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends."  We cannot promise future returns.  Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events.  The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire:


Information provided on about medical conditions, symptoms, and related products is not intended to be a substitute for professional medical advice. Visitors to this site should not use this information to diagnose or treat a health problem, symptom, concern or disease without consulting with their individual qualified healthcare provider. Statements contained on this website have not been evaluated by the FDA. Herborium products are not intended to diagnose, heal, cure or prevent disease.